President & Representative Director, COSMOS Pharmaceutical Corporation
Other assets (est.): the sum of each year's after-tax income (pay + dividends in own name − estimated taxes and social insurance) dividends retained by asset-management companies (less about 20% corporate tax), and proceeds from share sales (the drop in shares from the previous year × share price, less 20.315% tax, or about 30% for asset-management companies), for the years we have data. Spending, real estate, donations and savings from earlier years are not reflected.
| Company | Held by | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|---|
| COSMOS Pharmaceutical Corporation 3349 · FY ending May 2026 · President & Representative Director |
Own name | 26,000 | — | ¥6,024 | ¥157M | ¥2.1M |
| Year | Net worth | Pay | Dividends | Total income | Taxes (est.) | After tax (est.) | Share sales (after tax) |
|---|---|---|---|---|---|---|---|
| 2026 | ¥157M | ¥23.2M | ¥2.1M | ¥25.4M | ¥7.1M | ¥16.3M | — |
| 2025 | ¥230M | ¥31.0M | ¥1.8M | ¥32.8M | ¥11.3M | ¥19.5M | — |
| 2024 | ¥165M | ¥25.5M | ¥1.6M | ¥27.1M | ¥8.2M | ¥16.9M | — |
Grouped by the calendar year of each company's fiscal year-end. Years in which the person was not among the top 10 shareholders of a company exclude that company.